ArrowMark Colorado Holdings’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$182K Sell
83,659
-1,235,236
-94% -$2.69M ﹤0.01% 299
2025
Q1
$3.6M Sell
1,318,895
-38,808
-3% -$106K 0.06% 201
2024
Q4
$5.65M Sell
1,357,703
-37,244
-3% -$155K 0.08% 185
2024
Q3
$5.43M Buy
1,394,947
+169,250
+14% +$658K 0.07% 185
2024
Q2
$4.8M Sell
1,225,697
-32,503
-3% -$127K 0.06% 205
2024
Q1
$5.27M Sell
1,258,200
-115,577
-8% -$484K 0.06% 211
2023
Q4
$6.46M Sell
1,373,777
-1,035,261
-43% -$4.87M 0.07% 187
2023
Q3
$7.52M Sell
2,409,038
-167,222
-6% -$522K 0.09% 160
2023
Q2
$11.8M Buy
2,576,260
+277,186
+12% +$1.27M 0.13% 137
2023
Q1
$11.4M Buy
2,299,074
+40,842
+2% +$202K 0.13% 128
2022
Q4
$12.3M Buy
2,258,232
+30,133
+1% +$165K 0.15% 120
2022
Q3
$14.5M Buy
2,228,099
+73,862
+3% +$480K 0.18% 115
2022
Q2
$10.2M Buy
2,154,237
+861,524
+67% +$4.08M 0.12% 157
2022
Q1
$9.04M Buy
1,292,713
+70,963
+6% +$496K 0.08% 199
2021
Q4
$12.5M Buy
1,221,750
+43,826
+4% +$447K 0.1% 172
2021
Q3
$14.4M Buy
+1,177,924
New +$14.4M 0.11% 153